Summary.-We report observations on the spread by metastasis and infiltration of a transplantable tumour in rats treated by 6OCo y-irradiation of the primary, irradiation plus parenteral cyclophosphamide, or parenteral cyclophosphamide alone. The proportion of animals with overt disseminated disease and the extent of spread were measured with respect to the time elapsed after implantation and treatment of the primary tumour. The incidence of metastatic disease was broadly similar for all treatment groups, but the extent of dissemination was greater in rats whose treatment included cyclophosphamide.
IN the treatment of patients with cancer, the use of cytotoxic drugs as adjuvants to radiotherapy and surgery has become increasingly common (e.g. Choi and Carey, 1976) . The probability of local control of a primary tumour may be increased by the independent cytotoxicity of these agents and by their modification of the response of malignant clonogenic cells to subsequent irradiation (Bleehen, 1973) . We have carried out an experimental study on the response to combined treatment of a transplantable metastasizing mammary tumour in rats, using the alkylating agent cyclophosphamide (CP) in various combinations with radiotherapy (Moore, 1976) . However, in clinical practice the major rationale for the adjuvant use of systemic chemotherapeutic agents has been their potential action on tumour metastases outside the irradiated volume (Tucker et al., 1973; Roswit et al., 1976) .
Whereas an "aggressive"regime of chemotherapy may favour destruction of metastases, it will also invariably produce a deleterious effect on the host (Slavin, Millan and Mullins, 1975) . Should clonogenic cells of a metastasizing primary tumour survive a combined treatment, the environment into which they or their progeny are released may well differ from that prior to treatment. In our experimental mammary tumour, its propensity to metastasize was already known (Fig. 1) . Accordingly, during studies of combined high-dose chemotherapy and irradiation of primary tumours, postmortem examination (PM) of rats was carried out routinely. The data obtained, which are reported in this paper, enable the incidence of local infiltration and distant metastasis and the extent of spread to be quantitated in relation to the treatment employed.
MATERIALS AND METHODS
"John's strain" Wistar rats, sib-mated since 1939 (Thomlinson, 1960) were implanted with experimental tumours upon reaching a body weight of 150-200 g. Tumours were derived by serial transplantation from a spontaneous isogeneic mammary adenocarcinoma designated LMC1. Details of the origin and growth characteristics of this tumour have been reported elsewhere (Moore and Dixon, 1977, in preparation) . The chemotherapy and irradiation experiments from which data on infiltration and metastasis in 236 rats were derived were carried out with the 37th to 40th transplant generations, at in the abdominal flank, as a pellet of tumour mince contained within a "sausage skin" of gut from a 50-g isologous rat (Thomlinson, 1960) . Before implantation, the pellets were rinsed for 1 min in sterile distilled water to lyse tumour cells that might have adhered to their outer surface during preparation. Implanted pellets produced tumours which grew initially as encapsulated spheres unattached to skin or adjacent body wall and which attained within 10-12 days of implantation a mean diameter of 8-10 mm, at which size one of the following treatments was given:
1. Irradiation (500-7000 rad). (Thomlinson and Craddock, 1967; Moore, 1976 3. Metastases to the ipsilateral axillary lympatic nodes. 4. Metastases to the ipsilateral paraaortic nodes. Metastatic tumour was also found at other locations, e.g. the suprarenal lymphatics and thymus, but at a much lower frequency. Accordingly, subsequent analysis of data, for control animals and for treated groups, was confined to observations made at the 4 major sites listed above.
Overall, 45o% of animals showed evidence of tumour spread at PM. More detailed analysis showed no direct correlation between incidence of positive PM and size of dose of CP or radiation, either alone or in combination. However, the variation in delay in growth of the primary due to the various treatments enabled a comparison of metastatic rate (Table) .
Thus data were analysed with respect to the time elapsed between tumour implantation, treatment and PM. This clearly showed (Fig. 3) In treated animals which were positive for tumour at PM, data were further analysed with respect to the total number of major sites in the body liable to be positive for disseminated growth (Fig. 5) . In those animals in which the primary tumour was given radiation alone, the probability of tumour dissemination to more than one site increased only slowly with time. For rats treated by CP alone, the data are equivocal at the shorter time intervals, i.e., the extent of metastatic spread is higher, but not significantly so, compared to irradiated animals. However, among the extent of metastatic spread was significantly greater than after irradiation alone.
DISCUSSION
The method of implantation used in this study probably militates against the early metastatic spread of tumour, possibly up to the time of treatment of the primary or shortly thereafter. However, this has yet to be tested by PM of animals after surgical removal of primary tumours at 8-10 mm diameter. Thus at this stage, explanation of mechanisms underlying the observed differences in the dissemination of LMC1 tumour in rats given single or combined treatment are necessarily conjectural. Regardless of mechanisms, some of which are discussed below, the reported data underline the complexities of combination treatment of primary metastasizing tumours, when an aggressive first approach to chemotherapy may, in the event of failure, prejudice further attempts at cure of the disease.
If it is assumed that dispersion of LMC1 tumour cells did occur shortly after Sharpington, 1971; Sheldon and Fowler, 1973) . Conversely CP, alone or in combination, should exert its cytotoxic effect on both the primary and metastatic foci. For the former, 150 mg/kg CP delays growth by approximately 15 days (Moore, 1976) . One might therefore expect that such a dose would destroy, or at least markedly inhibit the growth of, metastases which contain far fewer cells of presumably equal or greater sensitivity to CP (Steel and Adams, 1975; Twentyman and Bleehen, 1976) . Thus in drug-treated rats, the recorded incidence of disseminated disease should be initially lower than in rats with irradiated tumours.
However, for short delays in growth of the primary (20-60 days), the incidence of positive PM was slightly higher in drugtreated than in irradiated rats, and with the shortest delay produced (20-40 days) was significantly higher when the drug was used in combination with radiation (Fig. 4) .
If occult metastatic foci were not present at treatment, or the pretreatment contribution to spread was small, the data reflect wholly or mainly dissemination of clonogenic cells from the primary tumour in the conditions prevailing during or after treatment. Thus regimes that do not sterilize, but only produce an increasing delay in growth of the primary, would permit an increasing incidence of overt tumour spread, irrespective of the mode of treatment (Fig. 3) . For drug alone or irradiation alone, this appears to have been the case, but at short intervals after combination treatment, the incidence was unexpectedly great (Fig. 4) and remained high thereafter, other than at 80-99 days for which results were obtained from only 2 animals. With this one exception, the incidence after CP or CP -+y was as high or higher than that after irradiation alone and, at later times the extent of spread was markedly greater after the combination (Fig. 5) . Others have speculated that such "potentiation" of dissemination by a cytotoxic agent might be attributed to suppression of an immunological response to tumour (Sugarbaker, Cohen and Ketcham, 1970; Brunner, Marthaler and Muller, 1971) . Cyclophosphamide is a potent immunosuppressive agent, particularly at high dosage (Harris et al., 1976) .
The LMC1 mammary tumour was of spontaneous origin and maintained in an inbred strain of rats. It has been claimed that specific immunological responses may sometimes be detected in animals bearing such tumours (Baldwin and Embleton, 1975) . If so, the high initial incidence, and greater extent of spread of LMC1 after combined treatment might be accounted for by a failure of surveillance. If, however, rejection responses to this kind of tumour do not occur (Hewitt, 1976) other explanations for the effect of CP must be sought; for example, greater lodgement of metastatic cells in tissues which have been subjected to non-specific trauma (Fisher, Fisher and Feduska, 1967) .
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